drugset / Trial / NCT01299467
A Study To Assess The Duration Of Action Of PF-03526299 In Asthmatic Subjects Following Allergen Challenge
RandomizedCrossoverTriple-blind
Summary
The purpose of this study is to find out how long the effect of PF-03526299 last after it is inhaled by assessing the lung function of mild asthma patients after they have been exposed to allergen
Timeline
- Start
- 2011-02
- Primary completion
- 2012-02
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-03526299 | Unknown | 1.396 mg | Inhaled |
| Subject | PF-03526299 | Unknown | 4.188 mg | Inhaled |